George Matsopoulos | Medical Imaging | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. George Matsopoulos | Medical Imaging | Best Researcher Award

Mengchao Wei | Venous thromboembolism | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Mengchao Wei | Venous thromboembolism | Best Researcher Award

Dr. Mengchao Wei, Peking Union Medical College Hospital, China

Dr. Mengchao Wei is a physician at Peking Union Medical College Hospital, China, specializing in Urology. He graduated with a Doctor’s degree from Sun Yat-sen University in 2019. Since joining PUMCH in 2021, Dr. Wei has focused on optimizing perioperative management for urologic surgeries. He developed a predictive model for venous thromboembolism risk post-surgery, now integrated into clinical practice. Dr. Wei has published 10 journal articles in SCI and Scopus indexed journals. His research aims to improve patient safety and surgical outcomes, making significant contributions to the field of urologic surgery.

Author Profile

Orcid Profile

๐Ÿ“šEarly Academic Pursuits:ย 

Dr. Mengchao Wei graduated with a Doctor’s degree from Sun Yat-sen University in 2019. His academic journey laid the foundation for his current work, particularly in the field of Urology, where he became deeply involved in understanding the nuances of perioperative management in urologic surgeries. His comprehensive training and early research set him on a path to clinical excellence and innovation.

โš•๏ธProfessional Endeavors and Contributions:ย 

Since 2021, Dr. Wei has been practicing as a Physician at Peking Union Medical College Hospital, where his focus lies in the optimization of perioperative management in urologic surgeries. His clinical work has had a direct impact on improving patient care and the efficiency of surgical outcomes. Dr. Wei’s contributions include the development of a predictive model for venous thromboembolism risk following urologic surgeries, which has been implemented in real-world clinical practice to enhance patient safety.

๐Ÿ”ฌResearch Focus and Innovations on Venous thromboembolism:

Dr. Wei’s research centers on perioperative management within urology, particularly concerning venous thromboembolism (VTE) risk. His predictive model for VTE risk, now utilized in clinical settings, showcases his ability to translate research into tangible, life-saving outcomes. While his citation index stands at 10, his work continues to gain attention in the medical community. He has published 10 journals in esteemed databases such as SCI and Scopus, reinforcing his status as a respected figure in urologic research.

๐ŸŒImpact and Influence:ย 

Dr. Wei’s contributions have not only benefited his hospital but also shaped the way urologic surgeries are managed perioperatively. By providing a tool that enhances clinical decision-making, he directly improves surgical outcomes, patient safety, and overall healthcare efficiency. His work has influenced peers, setting a new standard in the field of urology.

๐Ÿ“‘Academic Citations:

Dr. Wei has an impressive citation index of 10, a reflection of the growing recognition of his work and the clinical value it brings. His research continues to receive acknowledgment in relevant medical journals, contributing to the advancement of perioperative care in urology.

๐Ÿš€Legacy and Future Contributions:ย 

Dr. Wei’s research and innovations indicate a promising future in the field of urology. He is committed to enhancing perioperative management for urologic surgeries and advancing clinical practices. Moving forward, his aim is to refine predictive models and further contribute to patient safety and surgical excellence.

๐ŸŒŸConclusion:

Dr. Mengchao Wei’s work at Peking Union Medical College Hospital has made a significant impact on perioperative management in urologic surgeries. His predictive model for venous thromboembolism risk has been successfully integrated into clinical practice, improving patient outcomes and safety. With 10 journal publications in SCI and Scopus indexed journals, Dr. Wei is recognized as a dedicated and innovative physician. His contributions are shaping the future of urologic surgery. As he continues to push the boundaries of medical research, his work promises to enhance the quality of care and patient safety worldwide.

Top Notable Publicationsย 

A nomogram predicting the risk of venous thromboembolism in patients following urologic surgeries

Authors: Mengchao Wei

Journal: Scientific Reports

Year: 2025

The role of antimicrobial prophylaxis in laparoscopic nephrectomy for renal cell carcinoma

Authors: Mengchao Wei

Journal: BMC Urology

Year: 2024

Comparison of AirSeal versus conventional insufflation system for retroperitoneal robot-assisted laparoscopic partial nephrectomy: a randomized controlled trial

Authors: Mengchao Wei

Journal: World Journal of Urology

Year: 2024

Surgery or external beam radiation for solitary small hepatocellular carcinoma

Authors: Mengchao Wei

Journal: Journal of Cancer Research and Therapeutics

Year: 2023

Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy

Authors: Mengchao Wei

Journal: Frontiers in Oncology

Year: 2022

Role of Preoperational Imaging Traits for Guiding Treatment in Single โ‰ค 5 cm Hepatocellular Carcinoma

Authors: Mengchao Wei

Journal: Annals of Surgical Oncology

Year: 2022

The Combination of Radiation Therapy and Immunotherapy Is Effective and Well-Tolerated for Unresectable Biliary Tract Cancer

Authors: Mengchao Wei

Journal: International Journal of Radiation Oncology, Biology, Physics

Year: 2022

Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A

Authors: Mengchao Wei

Journal: Annals of Surgical Oncology

Year: 2020

Radiofrequency ablation plus nucleotide analogues for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis

Authors: Mengchao Wei

Journal: American Journal of Translational Research

Year: 2018

Sorafenib versus Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis

Authors: Mengchao Wei

Journal: BMC Cancer

Year: 2018

xie zhengxing | Cardiovascular Disease | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Prof. xie zhengxing | Cardiovascular Disease | Best Research Article Awardย 

Xiaodong Jiang | Critical Care Medicine | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Mr. Xiaodong Jiang | Critical Care Medicine | Best Researcher Awardย 

Mr. Xiaodong Jiang, Second Affiliated Hospital of Dalian Medical University, China

Mr. Xiaodong Jiang is a Chief Physician and Doctoral Researcher in Critical Care Medicine at the Second Affiliated Hospital of Dalian Medical University, China. As Deputy Director of the Critical Care Medicine Department, he excels in ECMO techniques and the management of severe and complex critical conditions. He is also a Master’s Supervisor, Party Branch Secretary, and Deputy Director of the Critical Care Medicine Teaching and Research Office. Actively involved in national and regional medical committees, he contributes to advancing critical care practices and education. His work in clinical innovation and academic leadership establishes him as a prominent expert in critical care medicine.

Author Profile

Scopus Profile

๐ŸŽ“EARLY ACADEMIC PURSUITS:

Mr. Jiang Xiaodong embarked on his academic journey with a clear focus on critical care medicine, quickly distinguishing himself as a dedicated scholar. His early studies laid the foundation for his expertise in managing life-threatening conditions, paving the way for his role as a Chief Physician and Doctoral Researcher. His academic excellence and commitment to learning were evident as he advanced through rigorous medical training and specialized in critical care medicine.

๐ŸฉบPROFESSIONAL ENDEAVORS:

Mr. Jiang serves as the Deputy Director of the Critical Care Medicine Department and Deputy Director of the Critical Care Medicine Teaching and Research Office at the Second Affiliated Hospital of Dalian Medical University. In these roles, he combines clinical expertise with administrative responsibilities, ensuring the seamless functioning of critical care units and fostering innovation in patient care.

Additionally, as the Secretary of the Critical Care Medicine Party Branch, he demonstrates exemplary leadership, influencing policies and practices within the hospital’s critical care division.

๐Ÿ”ฌCONTRIBUTIONS AND RESEARCH FOCUS ON CRITICAL CARE MEDICINE:

Mr. Jiangโ€™s research focus includes groundbreaking work in ECMO (Extracorporeal Membrane Oxygenation) treatment techniques, such as VV-ECMO, VA-ECMO, and ECPR. His expertise has revolutionized the management of severe pneumonia, emergency PCI, and perioperative care for lung transplants.

His contributions extend to the development of advanced rescue strategies for critical conditions, solidifying his status as a leading innovator in critical care medicine. His research findings have practical applications, improving patient survival rates and recovery outcomes.

๐ŸŒŸIMPACT AND INFLUENCEย 

Through his academic and professional positions, Mr. Jiang has significantly influenced critical care medicine at both regional and national levels. His active membership in various medical committees, including the Chinese Medical Doctor Association and Liaoning Medical Association, highlights his role in shaping critical care policies and advancing best practices.

His leadership extends to academic and clinical education, mentoring young professionals, and fostering the next generation of critical care specialists.

๐Ÿ“ACADEMIC CITES AND EDITORIAL CONTRIBUTIONS:ย 

Mr. Jiang is a recognized authority in his field, serving as an invited reviewer for prestigious journals, including the Chinese Journal of Emergency Medicine and the Chinese Journal of Critical Care Medicine.

As an Editorial Board Member of the Chinese Journal of Postgraduate Medical Education, he ensures the dissemination of high-impact research, further enhancing the academic landscape of critical care medicine.

๐ŸŒLEGACY AND FUTURE CONTRIBUTIONS:ย 

Mr. Jiangโ€™s legacy is defined by his unwavering commitment to advancing critical care medicine. His work in ECMO techniques, patient-centered care, and innovative research sets a benchmark for excellence.

Looking to the future, Mr. Jiang is poised to continue his groundbreaking research and expand his influence, leaving an indelible mark on critical care medicine. His dedication inspires colleagues and students alike, ensuring that his contributions will resonate for years to come.

๐Ÿ†FINAL REMARKS AND RECOGNITION:

Mr. Jiang Xiaodong embodies the qualities of a distinguished researcher, clinician, and academic leader. His comprehensive achievements in critical care medicine make him a deserving candidate for any accolade recognizing excellence and innovation in medical science. Recognizing his contributions will not only honor his work but also inspire continued progress in the field of critical care medicine.

๐ŸŒŸCONCLUSION:

Mr. Xiaodong Jiang stands as a beacon of excellence in critical care medicine, seamlessly blending clinical expertise, academic leadership, and innovative research. His groundbreaking work in ECMO techniques and dedication to improving patient outcomes have set new standards in the field. Through his roles in education and professional organizations, he continues to inspire the next generation of medical professionals.

With his unwavering commitment to advancing critical care practices, Mr. Jiang’s contributions will leave a lasting impact on the medical community. He is a true leader and innovator, deserving of recognition and admiration.

TOP NOTABLE PUBLICATIONS:

Machine learning for predicting acute myocardial infarction in patients with sepsis

Authors: Fang, S., Jin, H., Zhang, J., Su, W., Jiang, X.

Journal: Scientific Reports

Year: 2024

Case report: Rare intrapulmonary malignant mesothelioma complicated with myositis

Authors: Gong, D., Yu, J., Jiang, X.

Journal: Frontiers in Oncology

Year: 2022

Effect of MIR-26a targeting GSK-3ฮฒ/ฮฒ-catenin signaling pathway on myocardial apoptosis in rats with myocardial ischemia-reperfusion

Authors: Gong, D.-D., Yu, J., Yu, J.-C., Jiang, X.-D.

Journal: European Review for Medical and Pharmacological Sciences

Year: 2019

Takotsubo-like cardiomyopathy in a giant pheochromocytoma

Authors: Zhu, D., Yu, J., Li, X., Jiang, X., Zhuang, C.

Journal: International Journal of Cardiology

Year: 2014

Quan Yuan | Cardiovascular| Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Quan Yuan | Cardiovascular | Best Researcher Awardย 

Prof. QuanYuan, Wuhan University, China

Professor Quan Yuan, a distinguished researcher at Wuhan University, specializes in analytical chemistry with a focus on developing innovative methods for complex sample analysis. His pioneering work includes creating high-sensitivity field-effect transistor-based biosensors for the detection of myocardial injury biomarkers, significantly advancing rapid and accurate heart disease diagnosis. With over 139 journal publications, an H-Index of 41, more than 6,070 citations, 9 patents, and 2 authored books, Professor Yuan’s contributions are widely recognized. As Deputy Editor of “Sensors & Diagnostics” and a key member of multiple professional committees, he exemplifies excellence in research, leadership, and scientific innovation.

Author Profile

Orcid Profile

Education:

Professor Quan Yuan has an outstanding educational background that has shaped his career in analytical chemistry and biosensor technology. He earned his undergraduate degree in Chemistry from a prestigious institution in China, where he developed a strong foundation in chemical principles and experimental techniques. He pursued his masterโ€™s degree, specializing in analytical methods, which laid the groundwork for his innovative research. Professor Yuan completed his Ph.D. in Analytical Chemistry, focusing on advanced biosensor development for medical applications. His academic journey reflects a commitment to excellence, equipping him with the expertise to contribute significantly to science, innovation, and education.

Professional Experience:

Professor Quan Yuan has extensive professional experience in both academia and industry. He has led multiple research projects, including the development of highly sensitive biosensors for myocardial injury biomarkers, which have advanced clinical diagnostic methods. As a Deputy Editor for prominent journals such as Sensors & Diagnostics and Chinese Journal of Chemistry, he actively contributes to the scientific community. Professor Yuan has collaborated on various consultancy projects and has worked with leading organizations to translate his research into practical applications. His contributions span across over 6,000 citations and numerous patents, solidifying his reputation as a leading figure in his field.

Research skills:

Professor Quan Yuan possesses exceptional research skills in analytical chemistry and biosensor development. His expertise lies in designing high-sensitivity detection methods, particularly for complex samples such as body fluids and tissues. He has developed a field-effect transistor-based biosensor capable of detecting multiple myocardial injury biomarkers, using advanced machine learning algorithms for risk assessment and prognosis monitoring. His proficiency in integrating circuit technology with biosensors has led to the creation of a portable analysis system for rapid clinical diagnostics. Professor Yuan’s skills in both experimental design and data interpretation, alongside his interdisciplinary approach, have significantly impacted the medical diagnostics field.

Awards and Honors:

Professor Quan Yuan has received numerous awards and honors in recognition of his groundbreaking contributions to analytical chemistry and biomedical diagnostics. His research has earned him significant recognition in the scientific community, including over 6,070 citations and an H-Index of 41. He holds 9 patents and has published extensively in prestigious journals. In addition to his research achievements, Professor Yuan serves as Deputy Editor for “Sensors & Diagnostics” and the “Chinese Journal of Chemistry.” He is actively involved in several professional committees, including the Chinese Chemical Society and the China Medical Equipment Association, showcasing his leadership in advancing scientific innovation.

Conclusion:

Professor Quan Yuanโ€™s exceptional research and groundbreaking innovations in analytical chemistry, particularly in the development of advanced biosensors for heart disease diagnosis, make him a highly deserving candidate for the Best Researcher Award. His pioneering work has not only advanced scientific understanding but also led to practical applications in clinical diagnostics, improving patient care. With a remarkable publication record, numerous patents, and influential roles in editorial and professional committees, Professor Yuanโ€™s leadership in both research and academia has significantly impacted the field. His ongoing contributions continue to shape the future of medical diagnostics and scientific innovation.

Top Notable Publications

Persistent luminescence encoding for rapid and accurate oral-derived bacteria identification

Authors: Not provided

Journal: Chinese Chemical Letters

Year: 2025

Staggered-Stacking Two-Dimensional Covalent Organic Framework Membranes for Molecular and Ionic Sieving

Authors: Not provided

Journal: ACS Nano

Year: 2024

Bioโ€Inspired Multiple Responsive NIR II Nanophosphors for Reversible and Environmentโ€Interactive Information Encryption

Authors: Not provided

Journal: Advanced Materials

Year: 2024

Framework nucleic acid strategy enables closer microbial contact for programming short-range interaction

Authors: Not provided

Journal: Science Advances

Year: 2024

Defect Regulation Strategy of Porous Persistent Phosphors for Multiple and Dynamic Information Encryption

Authors: Not provided

Journal: Small Methods

Year: 2024

DNA Nanomaterial-Based Electrochemical Biosensors for Clinical Diagnosis

Authors: Not provided

Journal: ACS Nano

Year: 2024

Smart Persistent Luminescence Imaging for Early Diagnosis of Drug-Induced Liver Injury

Authors: Not provided

Journal: Chemical & Biomedical Imaging

Year: 2024

Thermodynamics and Kineticsโ€Directed Regulation of Nucleic Acidโ€Based Molecular Recognition

Authors: Not provided

Journal: Small Methods

Year: 2024

Bionic Potassium Ion Channel in Live Cells Repairs Cardiomyocyte Function

Authors: Not provided

Journal: Journal of the American Chemical Society

Year: 2024

Selfโ€Powered and Selfโ€Recoverable Multimodal Force Sensors Based on Trap State and Interfacial Electron Transfer

Authors: Not provided

Journal: Angewandte Chemie International Edition / Angewandte Chemie

Year: 2024

Menghua Xiong | Nanomedicine | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Menghua Xiong | Nanomedicine | Best Researcher Award

Prof. Menghua Xiong, South China University of Technology, China

Prof. Menghua Xiong is a professor at the School of Biomedical Sciences and Engineering at South China University of Technology, Guangzhou, China. He earned his B.E. and Ph.D. in Polymer Science and Engineering from the University of Science and Technology of China (USTC), where he worked under the mentorship of Prof. Jun Wang. Prof. Xiong completed postdoctoral research at the University of Illinois at Urbana-Champaign in the Department of Materials Science and Engineering, working with Prof. Jianjun Cheng. His research focuses on advanced polymers, drug delivery systems, and biomedical materials, contributing significantly to the development of novel materials for medical applications.

Author Profile

Orcid Profile

Google Scholar

๐ŸŽ“EARLY ACADEMIC PURSUITS:

Prof. Menghua Xiong began his academic journey in September 2003 at the University of Science and Technology of China (USTC), where he earned his Bachelor of Engineering (B.E.) degree in Polymer Science and Engineering in July 2007. He continued his studies at USTC, completing a Ph.D. in Polymer Science and Engineering under the guidance of Prof. Jun Wang from September 2007 to June 2013.

๐ŸซPROFESSIONAL ENDEAVORS:

After completing his doctoral studies, Prof. Xiong pursued postdoctoral research at the University of Illinois at Urbana-Champaign (UIUC) from July 2013 to December 2017. During this period, he worked in the Department of Materials Science and Engineering under the mentorship of Prof. Jianjun Cheng, gaining valuable experience in materials science and engineering. In January 2018, Prof. Xiong joined the School of Biomedical Sciences and Engineering at the Guangzhou International Campus of South China University of Technology as a professor, where he currently holds a faculty position.

๐Ÿ”ฌCONTRIBUTIONS AND RESEARCH FOCUS ON NANOMEDICINE:

Prof. Xiong’s research focuses on polymer science and biomedical engineering, with significant contributions to the development of advanced materials for biomedical applications. His work spans areas such as the synthesis and design of novel polymers, drug delivery systems, and biomaterials for medical use. He has made noteworthy advancements in the intersection of materials science, biomedical engineering, and polymer chemistry.

๐Ÿ“ˆIMPACT AND INFLUENCE:

Prof. Xiong has been influential in the field of polymer science and biomedical engineering, contributing to key developments in the design of functional materials for drug delivery and tissue engineering. His research has led to innovations that have applications in the medical field, impacting drug delivery systems and materials used in medical devices. He is also known for his collaborations with international researchers and for mentoring future scientists in the field.

๐Ÿ“šACADEMIC CITATIONS:

Prof. Xiong has received recognition for his research in terms of academic citations, with his work being referenced by researchers in polymer science, materials engineering, and biomedical fields. His publications have contributed to the advancement of knowledge in areas such as polymer synthesis, biomedical materials, and drug delivery technologies.

๐ŸŒŸLEGACY AND FUTURE CONTRIBUTIONS:

Prof. Xiong’s legacy is marked by his dedication to advancing the field of polymer science and biomedical engineering. His future contributions are expected to focus on further innovations in biomaterials, particularly in areas like personalized medicine, advanced drug delivery systems, and tissue engineering. As a mentor and researcher, Prof. Xiong continues to influence the development of the next generation of scientists and researchers in these fields.

๐ŸŒCONCLUSION:

Prof. Menghua Xiong is a prominent figure in the fields of polymer science and biomedical engineering, with a strong academic foundation from the University of Science and Technology of China (USTC) and valuable postdoctoral experience at the University of Illinois at Urbana-Champaign. His research contributions, particularly in the areas of polymer synthesis, drug delivery, and biomedical materials, have made a significant impact on advancing medical technologies. As a professor at South China University of Technology, Prof. Xiong continues to shape the future of biomedical sciences through his innovative work and mentorship of the next generation of researchers.

CITATIONS:

Citations –ย  4286
h-index –ย  27
i10-index –ย  29

TOP NOTABLE PUBLICATIONS

The Relationship between In Vivo Toxicity and Responsive pH in Transistorโ€Like pHโ€Sensitive Nanodetergents

Authors: Meng-Hua Xiong

Journal: Small Methods

Year: 2024

Helicity-directed recognition of bacterial phospholipid via radially amphiphilic antimicrobial peptides

Authors: Meng-Hua Xiong

Journal: Science Advances

Year: 2024

Stimuliโ€responsive linkers and their application in molecular imaging

Authors: Meng-Hua Xiong

Journal: Exploration

Year: 2024

Stimuli-responsive linkers and their application in molecular imaging (Preprint)

Authors: Meng-Hua Xiong

Journal: Exploration (Preprint)

Year: 2023

pH Window for High Selectivity of Ionizable Antimicrobial Polymers toward Bacteria

Authors: Meng-Hua Xiong

Journal: ACS Applied Materials & Interfaces

Year: 2023

A helical oncolytic polypeptide with potent membranolytic activity for cancer therapy

Authors: Meng-Hua Xiong

Journal: Biomaterials Science

Year: 2023

Nanoblock-mediated selective oncolytic polypeptide therapy for triple-negative breast cancer

Authors: Meng-Hua Xiong

Journal: Theranostics

Year: 2023

A transistor-like pH-sensitive nanodetergent for selective cancer therapy

Authors: Meng-Hua Xiong

Journal: Nature Nanotechnology

Year: 2022

Biomedical polymers: synthesis, properties, and applications

Authors: Meng-Hua Xiong

Journal: Science China Chemistry

Year: 2022

Modulation of Conformational Transition of Polypeptides under Slightly Acidic Environment

Authors: Meng-Hua Xiong

Journal: Chinese Journal of Chemistry

Year: 2022

Qian-Qian chen | Pharmacology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Qian-Qian chen | Pharmacology | Best Researcher Awardย 

Prof. Qian-Qian chen, Nanjing University of Chinese Medicine, China

Prof. Qian-Qian Chen is an Associate Professor at the School of Pharmacy at Nanjing University of Chinese Medicine, China. He holds a Ph.D. in Pharmacognosy from China Pharmaceutical University, Nanjing. His research focuses on the molecular mechanisms of cardiovascular and renal diseases, the regulatory effects of traditional Chinese medicine (TCM) on disease progression, and the role of the neuraminidase protein family in chronic conditions. Prof. Chen has published extensively in high-impact journals such as Advanced Science, Nature Communications, and European Heart Journal. He is committed to advancing both modern pharmacology and TCM in the context of chronic diseases.

Author Profile

Orcid Profile

๐ŸŽ“EARLY ACADEMIC PURSUITS:

Prof. Qian-Qian Chen began his academic journey with a Bachelor of Science in Pharmacy from Beihua University, Jilin, China, graduating in June 2015. Demonstrating exceptional academic potential, he pursued a Masterโ€™s degree in Pharmacy at China Pharmaceutical University, Nanjing, China, from September 2015 to July 2018. He further refined his expertise by completing a Ph.D. in Pharmacognosy at the same university, achieving his doctorate in July 2021.

๐ŸซPROFESSIONAL ENDEAVORS:

Currently serving as an Associate Professor and Masterโ€™s Supervisor in Pharmacology at the School of Pharmacy, Nanjing University of Chinese Medicine, Prof. Chen has been in this role since March 2022. His teaching and mentorship significantly contribute to nurturing the next generation of researchers in pharmacology and traditional Chinese medicine (TCM).

๐Ÿ”ฌCONTRIBUTIONS AND RESEARCH FOCUS ON Pharmacology:

Prof. Chenโ€™s research is primarily centered around the molecular mechanisms underlying cardiovascular and renal diseases. His work focuses on three major areas:
1๏ธโƒฃ Exploring the molecular pathways involved in cardiovascular and renal disease progression.
2๏ธโƒฃ Investigating the regulatory effects of traditional Chinese medicine (TCM) on these diseases.
3๏ธโƒฃ Unveiling the roles and mechanisms of the neuraminidase protein family in chronic conditions, including ventricular remodeling and chronic kidney injury.

His dedication to these fields has yielded a wealth of insights that advance understanding and treatment strategies for complex cardiorenal syndromes.

๐Ÿ“ˆIMPACT AND INFLUENCE:

Prof. Chen has made significant contributions to the scientific community through his publications in prestigious journals. These include:

  • Advanced Science (2024)
  • Nature Communications (2023)
  • European Heart Journal (2021)
  • Journal of Ethnopharmacology (2021)
  • The American Journal of Chinese Medicine (2021)
  • Circulation (2018)

His groundbreaking studies on cardiovascular and renal diseases have been highly cited and praised for their clinical relevance and innovative methodologies.

๐Ÿ“šACADEMIC CITES AND LEGACY:ย 

Prof. Chenโ€™s published work has been widely referenced in the fields of pharmacology, traditional Chinese medicine, and chronic disease research. His studies, particularly those addressing the interplay between cardiovascular and renal systems, serve as a cornerstone for researchers exploring related domains.

๐ŸŒŸFUTURE CONTRIBUTIONS AND VISION:

Looking ahead, Prof. Chen aims to:

  • Expand the understanding of traditional Chinese medicineโ€™s regulatory roles in disease mechanisms.
  • Advance therapeutic strategies for chronic diseases through interdisciplinary research.
  • Mentor emerging researchers, fostering innovation and excellence in pharmacological sciences.

His commitment to merging modern scientific techniques with traditional medicine holds the promise of revolutionary breakthroughs in healthcare.

๐ŸŒCONCLUSION:

Prof. Qian-Qian Chenโ€™s impressive academic trajectory, impactful research, and dedication to advancing pharmacology place him as a leading figure in his field. His work not only bridges the gap between traditional and modern medicine but also sets a foundation for transformative discoveries that will benefit patients worldwide.

Top Notable Publications:

Targeting Neuraminidase 4 Attenuates Kidney Fibrosis in Mice

Authors: Qian-Qian Chen

Journal: Advanced Science

Year: 2024

DOI: 10.1002/advs.202406936

Neuraminidase 1 is a Driver of Experimental Cardiac Hypertrophy

Authors: Qian-Qian Chen

Journal: European Heart Journal

Year: 2021

DOI: 10.1093/eurheartj/ehab347

Neuraminidase 1 and its Inhibitors from Chinese Herbal Medicines: An Emerging Role for Cardiovascular Diseases

Authors: Qian-Qian Chen

Journal: The American Journal of Chinese Medicine

Year: 2021

DOI: 10.1142/s0192415x21500403

PMID: 33827385

Untargeted Metabolomics and Lipidomics Uncovering the Cardioprotective Effects of Huanglian Jiedu Decoction on Pathological Cardiac Hypertrophy and Remodeling

Authors: Qian-Qian Chen

Journal: Journal of Ethnopharmacology

Year: 2020

DOI: 10.1016/j.jep.2020.113646

PMID: 33264659

Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases

Authors: Qian-Qian Chen

Journal: Circulation

Year: 2017

DOI: 10.1161/circulationaha.117.031139

PMID: 29212895

Mincai li | vascular calcification | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Mincai li | vascular calcification | Best Researcher Awardย 

Prof. Dr. Mincai li, Hubei University of Science and Technology, China

Prof. Dr. Mincai Li is a distinguished academic at Hubei University of Science and Technology, China. He holds an MD and Master’s degree in Pathology and Pathophysiology from Huazhong University of Science and Technology. With extensive experience in teaching, Prof. Li has served as a Professor since 2017, after roles as Associate Professor and Lecturer at the same institution. His research focuses on the molecular mechanisms of atherosclerosis and the efficacy of glioma drugs. He has published over 40 scientific papers, including 15 SCI-indexed articles, and has received multiple awards for his scientific and teaching contributions.

Author Profile

Scopus Profile

๐ŸŽ“ Education Background:

Prof. Dr. Mincai Li completed his MD in Pathology and Pathophysiology at Huazhong University of Science and Technology (2007-2010), graduating in the top 10% of his class. He also earned his Master’s in Pathology and Pathophysiology from the same institution (2004-2007), ranking in the top 10%. Prior to that, he obtained a Bachelor’s in Clinical Medicine from Hubei University of Science and Technology (1993-1998), where he was in the top 30% of his cohort.

๐Ÿ’ผ Professional Experience:

Prof. Dr. Mincai Li has an extensive academic career at Hubei University of Science and Technology, where he has held progressively senior roles. Since January 2017, he has served as a Professor, following his tenure as Associate Professor from January 2012 to December 2016. From July 2010 to December 2011, he was a Lecturer, and earlier in his career, he worked as a Teaching Assistant from July 1998 to August 2004. Throughout his tenure, Prof. Dr. Li has contributed significantly to education and research in his field, shaping the academic environment at the university.

๐Ÿฉบ Medical Education & Teaching:

Prof. Dr. Mincai Li has made significant contributions to medical education, primarily teaching Pathology and Oral Histopathology courses. He has played a leading role in three provincial teaching research projects within Hubei’s higher education institutions, demonstrating his commitment to advancing academic standards. His exceptional teaching efforts have been recognized with awards, including a second prize and a third prize for teaching achievements at Hubei University of Science and Technology. Prof. Dr. Li’s dedication to both education and research has made a lasting impact on the academic community and the development of future medical professionals.

๐Ÿ”ฌ Scientific Research:

Prof. Dr. Mincai Li’s research primarily focuses on the molecular mechanisms of atherosclerosis and the efficacy of glioma drugs. He has led and contributed to 10 national, provincial, and municipal research projects, showcasing his expertise in these critical areas. Prof. Li has published over 40 scientific papers, including 15 SCI-indexed articles, and has edited a textbook. His significant contributions to scientific research have earned him recognition, including a second prize and a third prize for scientific and technological progress in Xianning City. His work continues to advance the understanding of critical medical conditions and therapeutic approaches.

๐Ÿ… Achievements and Honors:

Prof. Dr. Mincai Li has earned several prestigious awards throughout his career. In 2015, he was honored with the Second and Third Prizes for Science and Technology Progress in Xianning City, recognizing his contributions to scientific advancement. In 2016, he received both the Second and Third Prizes for Teaching Achievements at Hubei Institute of Science and Technology, highlighting his dedication to education. That same year, Prof. Li was awarded the Third Prize for the Second Natural Science Outstanding Academic Achievement Thesis Award in Xianning City, further acknowledging his impactful research and academic excellence. These accolades reflect his commitment to both teaching and scientific progress.

๐ŸŒŸConclusion:

Prof. Dr. Mincai Li is a highly accomplished academic and researcher at Hubei University of Science and Technology, China. With a strong background in Pathology and Pathophysiology, he has made significant contributions to both education and scientific research. His work on atherosclerosis and glioma drugs has earned him national and regional recognition. As a dedicated professor, he has shaped the academic development of many students, while his research continues to advance medical science. Prof. Li’s numerous awards and honors reflect his unwavering commitment to excellence in both teaching and research.

Top Notable Publications:

Target analysis and identification of curcumin against vascular calcification

Authors: Li, Q., Zhou, Q., Li, S., Li, M., Xia, H.

Journal: Scientific Reports

Year: 2024

The causal relationship between thoracic aortic aneurysm and immune cells: a mendelian randomization study

Authors: Liu, G., Pan, S., Xia, H., Li, M., Wu, A.

Journal: BMC Cardiovascular Disorders

Year: 2024

Attenuating Atherosclerosis through Inhibition of the NF-ฮบB/NLRP3/IL-1ฮฒ Pathway-Mediated Pyroptosis in Vascular Smooth Muscle Cells (VSMCs)

Authors: Li, S., Li, Q., Zhou, Q., Liu, C., Li, M.

Journal: Cardiovascular Therapeutics

Year: 2024

Identification of key genes and pathways in atherosclerosis using integrated bioinformatics analysis

Authors: Li, S., Li, Q., Zhou, Q., Liu, C., Li, M.

Journal: BMC Medical Genomics

Year: 2023

Bioinformatic Identification of the Pyroptosis-Related Transcription Factor-MicroRNA-Target Gene Regulatory Network in Angiotensin II-Induced Cardiac Remodeling and Validation of Key Components

Authors: Huang, T., Ding, J., Lin, L., Yu, L., Li, M.

Journal: Frontiers in Bioscience (Landmark edition)

Year: 2023

Increased Neuromedin B is Associated with a Favorable Prognosis in Glioblastoma

Authors: Li, S., Li, Q., Zhou, Q., Liu, C., Li, M.

Journal: Frontiers in Bioscience – Landmark

Year: 2023

Study on mechanism of resveratrol regulation of NLRP3 mediated pyroptosis of vascular smooth muscle cells resistance to atherosclerosis

Authors: Li, S., Li, Q., Zhou, C., Ouyang, C., Li, M.

Journal: Drug Evaluation Research

Year: 2022

Curcumin suppresses glioblastoma cell proliferation by p-AKT/mTOR pathway and increases the PTEN expression

Authors: Wang, Z., Liu, F., Liao, W., Li, M., Xia, H.

Journal: Archives of Biochemistry and Biophysics

Year: 2020

Captopril Attenuates the Upregulated Connexin 43 Expression in Artery Calcification

Authors: Li, M., Wang, Z., Shao, J., Yu, L., Hu, Z.

Journal: Archives of Medical Research

Year: 2020

Yan Li | Nutrition | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Yan Li | Nutrition | Best Researcher Award

Prof. Dr. Yan Li, Jiangnan University, China

Yan Li is a Research Associate at the State Key Laboratory of Food Science and Technology, Jiangnan University, China. He earned his B.Sc. in Food Sciences and Engineering from Jiangnan University in 2012 and a Ph.D. in Biochemistry and Molecular Biology from the Institute for Nutritional Sciences, SIBS, CAS, in 2017. His research focuses on epigenetic regulation of glucose and lipid metabolism, therapeutic strategies for metabolic diseases like T2DM and obesity, and developing functional foods. Yan Li has received multiple honors, including the Young Elite Scientists Sponsorship Program by CAST (2021-2023), showcasing his contributions to advancing health and nutrition science.

Author Profile

Scopus Profile

Orcid Profile

Education Background:

Yan Li completed his education with a strong focus on food sciences and molecular biology. He earned his B.Sc. in Food Sciences and Engineering from Jiangnan University, China, in 2012, where he laid the foundation for his expertise in food technology. He then pursued a Ph.D. in Biochemistry and Molecular Biology at the Institute for Nutritional Sciences, SIBS, CAS, in Shanghai, completing it in 2017 under the supervision of Dr. Hao Ying. His doctoral research focused on cutting-edge areas of molecular biology, particularly epigenetic regulation and metabolic diseases, establishing a solid academic background for his research in health and nutrition.

Professional Experience:

Yan Li has been a Research Associate at the State Key Laboratory of Food Science and Technology, Jiangnan University, since 2017. In this role, he has conducted groundbreaking research on metabolic regulation, focusing on epigenetic mechanisms like microRNAs, acetylation, and lactylation, and their roles in glucose and lipid metabolism. His work extends to developing therapeutic strategies for metabolic disorders such as Type 2 Diabetes Mellitus (T2DM), obesity, and aging-related conditions. Additionally, he explores the functional properties of plant-based ingredients to innovate health and functional foods. Yan Liโ€™s professional experience reflects his dedication to advancing both scientific understanding and practical applications in metabolic health.

Research Interest:

Yan Li‘s research interests focus on the role of epigenetic regulation in metabolic processes, particularly how microRNAs, acetylation, and lactylation influence glucose and lipid metabolism, as well as energy homeostasis. He aims to uncover novel therapeutic strategies for metabolic diseases, including Type 2 Diabetes Mellitus (T2DM), Non-Alcoholic Fatty Liver Disease (NAFLD), aging, and obesity. Additionally, his work explores the mechanisms behind metabolism, exercise, muscle atrophy, and dystrophy, with an emphasis on skeletal muscle regulation. He is also dedicated to investigating the metabolic effects of functional ingredients in cereals and plants, seeking to develop innovative functional foods and health products.

Award and Honors:

Yan Li has received numerous prestigious awards and honors throughout his academic and professional career. These include multiple Outstanding Student Awards from the Chinese Academy of Sciences (2013-2015) and Jiangnan University (2010-2011). He was also recognized as an Outstanding Student Leader by the Chinese Academy of Sciences (2013-2014). In 2014-2015, he received the New World Scholarship from the same institution. Yan Li was awarded the Yihaikerry Teacher Award (2019-2020) and is a recipient of the Young Elite Scientists Sponsorship Program by CAST (2021-2023), highlighting his significant contributions to the field of food science and health research.

Conclusion:

Yan Li is a highly accomplished researcher whose work significantly contributes to the fields of food science, biochemistry, and molecular biology. His research on epigenetic regulation in metabolic diseases, such as Type 2 Diabetes Mellitus, obesity, and aging, alongside his innovative studies on functional foods, positions him as a leading expert in the field. With a solid educational background, extensive research experience, and a history of receiving prestigious awards, Yan Liโ€™s dedication to advancing scientific knowledge and practical health applications makes him a deserving candidate for recognition. His work has the potential to improve global health and nutrition, marking him as an influential researcher.

Top Notable Publications

“Unveiling the potential of germinated black bean extracts: Targeting topoisomerase IIฮฑ through in silico and in vitro approaches”

Journal: Food Chemistry

Year: 2025 ๐Ÿ“…

Citations: 0 ๐Ÿ“š

“Unveiling the microbiota-mediated impact of different dietary proteins on post-digestive processes: A simulated in vitro approach”

Journal: Food Research International

Year: 2024 ๐Ÿ“…

Citations: 0 ๐Ÿ“š

“Unveiling the structural and physico-chemical properties of glutenin macropolymer under frozen storage: Studies on experiments and molecular dynamics simulation”

Journal: Food Research International

Year: 2024 ๐Ÿ“…

Citations: 0 ๐Ÿ“š

“Sirtuin 3 reinforces acylcarnitine metabolism and maintains thermogenesis in brown adipose tissue of aging mice”

Journal: Aging Cell

Year: 2024 ๐Ÿ“…

Citations: 0 ๐Ÿ“š

“Modifications and in vitro absorption of 5-heptadecyresorcinol from cereals using digestion and ussing chamber models”

Journal: Food Research International

Year: 2024 ๐Ÿ“…

Citations: 0 ๐Ÿ“š

“Aqueous Extract of Wolfberry Alleviates Aging-Related Skeletal Muscle Dysfunction by Modulating PRRs Signaling Pathways and Enhancing DNA Repair”

Journal: Molecular Nutrition and Food Research

Year: 2024 ๐Ÿ“…

Citations: 0 ๐Ÿ“š

“Research progress of emulsifiers for baking”

Journal: Food and Fermentation Industries

Year: 2024 ๐Ÿ“…

Citations: 0 ๐Ÿ“š

“Maternal brown rice diet alleviates adverse effects of maternal obesity on offspring metabolism via enhancing DNA demethylation of AdipoR2”

Journal: Food Bioscience

Year: 2024 ๐Ÿ“…

Citations: 0 ๐Ÿ“š

“Maternal Dietary Carbohydrate and Pregnancy Outcomes: Quality over Quantity”

Journal: Nutrients

Year: 2024 ๐Ÿ“…

Citations: 0 ๐Ÿ“š

“Quinoa Polyphenol Extract Alleviates Non-Alcoholic Fatty Liver Disease via Inhibiting Lipid Accumulation, Inflammation, and Oxidative Stress”

Journal: Nutrients

Year: 2024 ๐Ÿ“…

Citations: 1 ๐Ÿ“š

 

Pingping Yang | Metabolism| Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Pingping Yang | Metabolism| Best Researcher Award

Dr. Pingping Yang,The Second Affiliated Hospital ,Jiangxi Medical College, Nanchang University, Nanchang, China

Dr. Pingping Yang, MD, is an accomplished researcher at Nanchang University, specializing in cardiovascular and nephrology medicine. She earned her Bachelorโ€™s, Masterโ€™s, and PhD degrees from Nanchang University, demonstrating academic excellence and dedication to her field. Over the past three years, Dr. Yang has published 16 SCI-indexed papers in renowned journals such as JAMA, Circulation, and Metabolism. Her expertise includes statistical analysis, meta-analysis, and network meta-analysis. Dr. Yang has received numerous accolades, including the National Scholarship and the First Prize for Excellent Paper. Her research contributions significantly impact cardiovascular and kidney disease studies, advancing scientific understanding globally.

๐ŸŒŸAuthor Profile

Scopus Profile

๐ŸŽ“Educationย 

Dr. Pingping Yang has an extensive educational background in clinical medicine and specialized fields. She earned her Bachelorโ€™s degree in Clinical Medicine from Nanchang University (2010-2015), laying a strong foundation in medical sciences. Following this, she pursued a Masterโ€™s degree in Nephrology at Nanchang University (2015-2018), where she developed specialized knowledge in kidney-related diseases. Demonstrating her commitment to advancing her expertise, Dr. Yang completed her PhD in Cardiovascular Medicine at Nanchang University (2018-2021), focusing on advanced cardiovascular research. Her academic journey reflects her dedication to medical science and her drive to contribute to critical areas of healthcare and research.

๐Ÿ’ผProfessional Experiencesย 

Dr. Pingping Yang has extensive professional experience in clinical medicine and research. From 2014 to 2015, she practiced at the Second Affiliated Hospital of Nanchang University, gaining hands-on clinical expertise. Between 2015 and 2018, she completed standardized residency training at the same institution, further honing her medical and diagnostic skills. As a dedicated researcher, Dr. Yang has published 16 SCI-indexed papers in prestigious journals, reflecting her expertise in cardiovascular and nephrology medicine. Her proficiency in statistical analysis, including meta-analysis and network meta-analysis, has strengthened her research outcomes, making significant contributions to advancing clinical and translational medical research.

๐ŸŒResearch Skillsย 

Dr. Pingping Yang possesses advanced research skills in cardiovascular and nephrology medicine, supported by her extensive academic and professional experience. She excels in statistical analysis, including meta-analysis, network meta-analysis, and proficiency with SPSS software, enabling her to produce high-quality, data-driven research. Dr. Yangโ€™s expertise includes conducting comprehensive literature reviews, designing and analyzing clinical studies, and interpreting complex data sets. Her ability to collaborate on multidisciplinary research has resulted in 16 SCI-indexed publications in top-tier journals like JAMA and Circulation. Dr. Yangโ€™s strong analytical abilities and methodological precision significantly contribute to advancing research in cardiovascular and kidney diseases.

ย ๐Ÿ…Awards And Honorsย 

Dr. Pingping Yang has received numerous awards and honors in recognition of her outstanding academic achievements and research contributions. She was awarded the National Scholarship in 2016 and 2017 for her exceptional performance. Additionally, she received the Special Grade Masterโ€™s Scholarship for three consecutive years (2015-2017), highlighting her dedication to academic excellence. Dr. Yangโ€™s research has been widely acknowledged, earning her the Excellent Poster Award at the CSN2016 Academic Conference and the First Prize for Excellent Paper at the 2017 Annual Conference of the Nephrology Branch of Jiangxi Medical Association. These accolades underscore her remarkable contributions to science.

Conclusionย 

Dr. Pingping Yangโ€™s exemplary academic achievements and research contributions make her a distinguished candidate for recognition. With 16 SCI-indexed publications in renowned journals such as JAMA, Circulation, and Metabolism, she has demonstrated a profound impact in cardiovascular and nephrology medicine. Her expertise in advanced statistical analysis, including meta-analysis and network meta-analysis, highlights her ability to produce data-driven, high-quality research. Recognized with prestigious awards like the National Scholarship and Excellent Paper Prize, Dr. Yangโ€™s work reflects innovation, dedication, and scholarly excellence. Her contributions not only advance scientific understanding but also set a benchmark for future research in her field.

ย  ๐Ÿ“–Publication Top Notes

  • ๐Ÿงช PD-1 agonist: A novel therapeutic approach to resolve atherosclerosis
    • Chen, J., Yu, W., Liao, L., Fu, L., Yang, P.
    • Results in Chemistry (2024)
    • ๐Ÿ“† Year: 2024 | ๐Ÿ”– Citations: 0
  • ๐Ÿ”ฌ The role of NLRP3 inflammasome in aging and age-related diseases
    • Liang, R., Qi, X., Cai, Q., Zhang, J., Yu, P.
    • Immunity and Ageing (2024)
    • ๐Ÿ“† Year: 2024 | ๐Ÿ”– Citations: 9
  • ๐Ÿ“Š Investigating the research trajectory and future trends of immune disorders in diabetes cardiovascular complications
    • Li, X., Xu, Z., Huang, T., Zhang, J., Yu, P.
    • Ageing Research Reviews (2024)
    • ๐Ÿ“† Year: 2024 | ๐Ÿ”– Citations: 0
  • ๐Ÿ“ฑ The status quo of short video as sources of health information on gastroesophageal reflux disease in China
    • Cai, Y., Zeng, H., Yang, P., Lai, Y., Zhou, Y.
    • Frontiers in Public Health (2024)
    • ๐Ÿ“† Year: 2024 | ๐Ÿ”– Citations: 0
  • ๐Ÿ’Š Effect of PCSK9 Monoclonal Antibody Versus Placebo/Ezetimibe on Atrial Fibrillation
    • Yang, S., Shen, W., Zhang, H.-Z., Yang, P.-P., Wu, Q.-H.
    • Cardiovascular Drugs and Therapy (2023)
    • ๐Ÿ“† Year: 2023 | ๐Ÿ”– Citations: 4
  • ๐Ÿฅ— Food-derived peptides as novel therapeutic strategies for NLRP3 inflammasome-related diseases
    • Zhang, Z., Zhang, Y., Zhang, M., Yu, P., Zhang, D.
    • Critical Reviews in Food Science and Nutrition (2023)
    • ๐Ÿ“† Year: 2023 | ๐Ÿ”– Citations: 2
  • ๐Ÿฆ  Role of NLRP3 inflammasome in diabetes and COVID-19
    • Zhang, J., Ma, X., Liu, F., Liu, J., Yu, P.
    • Frontiers in Immunology (2023)
    • ๐Ÿ“† Year: 2023 | ๐Ÿ”– Citations: 4
  • โค๏ธ Finerenone in treatment of cardiovascular and related diseases
    • Yu, W., Shen, W., Yang, P., Wu, T., Wu, Q.
    • Journal of Clinical Cardiology (2022)
    • ๐Ÿ“† Year: 2022 | ๐Ÿ”– Citations: 2
  • ๐Ÿ”ฅ Advances in T Cells Based on Inflammation in Metabolic Diseases
    • Yu, W., Li, C., Zhang, D., Zhang, M., Yu, P.
    • Cells (2022)
    • ๐Ÿ“† Year: 2022 | ๐Ÿ”– Citations: 13
  • ๐Ÿ’‰ Efficacy and safety of sacubitril/valsartan on heart failure with preserved ejection fraction
    • Yu, W., Zhang, H., Shen, W., Yang, P., Wu, Q.
    • Frontiers in Cardiovascular Medicine (2022)
    • ๐Ÿ“† Year: 2022 | ๐Ÿ”– Citations: 3